25 years of Cancer Research and Care on the Island of Ireland
Rosemarie Gannon, Project Manager, All Island Cancer Research Institute (AICRI); Richard Kennedy, Chair, InterTradeIreland; Margaret Hearty, CEO, InterTradeIreland; Prof. Mark Lawler, Professor, Digital Health, Queen's University Belfast and Co-Lead AICRI; Prof. William Gallagher, Professor, Cancer Biology, University College Dublin and Co-Lead AICRI; Dr. Stephen Chanock, Director, Division of Cancer Epidemiology and Genetics, National Cancer Institute
The Ireland - Northern Ireland – U.S. National Cancer Institute Cancer Consortium celebrates its 25th Anniversary this year. The Consortium is a unique partnership, established in 1999, between the governments of Ireland, Northern Ireland, and the United States, as a direct result of the Good Friday Agreement. This tripartite partnership aims to reduce cancer incidence and mortality on the island of Ireland through cross-border and transatlantic collaborations in cancer research and education.
The success of the partnership is evident particularly in the areas of training and capacity building. Over 500 healthcare professionals and scientists have been trained at NCI, many returning to help drive cancer research and its translation to better patient outcomes on the island of Ireland. NCI Director, Dr. W. Kimryn Rathmell, notes “Collaboration between nations can be a powerful stimulus for advancing cancer research. This is an exciting milestone anniversary for a partnership that has been so successful and beneficial for Ireland, Northern Ireland, and the United States." Read what others involved had to say about this long standing collaboration and its impact throughout the years.